Category: Family

Hyperglycemic crisis and diabetic foot ulcers

Hyperglycemic crisis and diabetic foot ulcers

Nat Hyperglycemic crisis and diabetic foot ulcers Endocrinol fokt 4 — Ulccers, the condition presents as an acutely inflamed Saturated fat sources with Hyperglycemic crisis and diabetic foot ulcers soft and bone tissue necrosis, associated with severe systemic complications, such as hyperglycemic crisis, acute cardiac or root event, and septic shock and so on. Significant increase of IL-6, -1B Hyperglyce,ic -8, and TNF-α and other cytokines reduce the response to insulin therapy. Diabetic PN is a heterogenous clinical entity but is broadly defined as any constellation of signs or symptoms of peripheral nerve dysfunction without another clear cause, presumed to be the result of both metabolic and vascular factors in the setting of chronic hyperglycemia These devices will take the pressure off of the ulcer area. Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. It seems that it is a protective factor for patients with hyperglycaemic crisis.

Hyperglycemic crisis and diabetic foot ulcers -

These range from normal saline to advanced products, such as growth factors, ulcer dressings, and skin substitutes that have been shown to be highly effective in healing foot ulcers.

For a wound to heal there must be adequate circulation to the ulcerated area. Your podiatrist may order evaluation test such as noninvasive studies and or consult a vascular surgeon.

Tightly controlling blood glucose is of the utmost importance during the treatment of a diabetic foot ulcer. Working closely with a medical doctor or endocrinologist to accomplish this will enhance healing and reduce the risk of complications.

A majority of noninfected foot ulcers are treated without surgery; however, when this fails, surgical management may be appropriate. Healing time depends on a variety of factors, such as wound size and location, pressure on the wound from walking or standing, swelling, circulation, blood glucose levels, wound care, and what is being applied to the wound.

Healing may occur within weeks or require several months. The best way to treat a diabetic foot ulcer is to prevent its development in the first place. Recommended guidelines include seeing a podiatrist on a regular basis.

He or she can determine if you are at high risk for developing a foot ulcer and implement strategies for prevention. Reducing additional risk factors, such as smoking, drinking alcohol, high cholesterol, and elevated blood glucose are important in the prevention and treatment of a diabetic foot ulcer.

Wearing the appropriate shoes and socks will go a long way in reducing risks. Your podiatric physician can provide guidance in selecting the proper shoes. Learning how to check your feet is crucial in noticing a potential problem as early as possible. Inspect your feet every day—especially between the toes and the sole—for cuts, bruises, cracks, blisters, redness, ulcers, and any sign of abnormality.

Each time you visit a health care provider, remove your shoes and socks so your feet can be examined.

Adapted from APMA. Updated visitor policies. Other Michigan Medicine Sites About Michigan Medicine UofMHealth.

org Medical School Nursing Find a Clinical Trial. Frequently Asked Questions: Diabetic Foot Ulcers. What Is a Diabetic Foot Ulcer? Who Can Get a Diabetic Foot Ulcer? How Do Diabetic Foot Ulcers Form?

What Is the Value of Treating a Diabetic Foot Ulcer? Foot ulcers in patients with diabetes should be treated for several reasons: To reduce the risk of infection and amputation To improve function and quality of life To reduce health care costs How Should a Diabetic Foot Ulcer Be Treated?

Applying Medication and Dressings Appropriate wound management includes the use of dressings and topically-applied medications.

Nerve damage is particularly problematic because it can cause numbness. For example, you might cut your foot and not even realize it.

This can increase the time it takes for you to clean the wound and seek treatment. Nerve damage combined with poor circulation can lead to slow-healing wounds. Not only are diabetic wounds slow-healing, but diabetic neuropathy also negatively impacts your immune system, which means if you have a wound, your body has a harder time fighting off bacteria and other pathogens, which may lead to infection.

Scheduling routine diabetic foot care appointments allows Dr. Nieto to inspect your feet for any red flags as well as trim your nails and remove calluses. In addition to routine diabetic foot care, you can further reduce your risk of developing a foot ulcer by:.

When you have high blood sugar, poor circulation, and peripheral neuropathy, even the smallest tissue injury such as a small blister can become problematic. Without the adequate circulation to promote healing, small injuries can quickly become infected. Diabetic wounds, including foot and leg ulcers, require immediate treatment.

If you have questions about foot ulcers and would like to schedule an appointment, call us at or use our online scheduling tool. Telemedicine options available. Learn more about our COVID response. Se habla Español. The Link Between High Blood Glucose and Foot Ulcers.

Diabetic Foot and Wound Center Blog The Link Between High Blood Glucose and Foot Ulcers.

Diabetes mellitus DM Hyperglydemic the metabolism Steady and natural weight loss primary macronutrients such as proteins, fats, and carbohydrates. Due to the Fish Species Conservation Programs prevalence Hypreglycemic DM, emergency admissions for hyperglycemic crisis, Fish Species Conservation Programs ketoacidosis DKA and hyperglycemic siabetic state HHS are fairly common and represent very challenging clinical management in practice. DKA and HHS are associated with high mortality rates if left not treated. DKA and HHS have similar pathophysiology with some few differences. HHS pathophysiology is not fully understood. However, an absolute or relative effective insulin concentration reduction and increased in catecholamines, cortisol, glucagon, and growth hormones represent the mainstay behind DKA pathophysiology.

Hyperglycemic crisis and diabetic foot ulcers -

However, higher mortality rates were reported among elderly patients diagnosed with DKA 1. DKA and HHS have similar pathophysiology with some differences.

The pathogenesis behind HHS is not as well understood 2 , 5. DKA is a complex metabolic disorder caused by an absolute or relative effective insulin concentration reduction and increased in catecholamines, cortisol, glucagon, and growth hormones 5 , 6. Hyperglycemia is explained by three main mechanisms: increased gluconeogenesis, accelerated glycogenolysis, and impaired glucose utilization by peripheral tissues 7.

Insulin reduction and increased counterregulatory hormones in DKA accelerate the lipolysis, which results in the release of free fatty acids into the circulation from adipose tissue and stimulates the conversion of fatty acid to ketone by liver oxidation 7 , 8.

This profound increase in free fatty acid and ketone concentrations lead to a further increase in the magnitude of hyperglycemia by inducing insulin resistance and ultimately results in ketonemia and metabolic acidosis 7 , 8.

Previous studies have shown that excessive glucose levels and fatty acids are associated with a pro-inflammatory and oxidative state among DKA patients 9 , Oxidative stress is defined as an increase in reactive oxygen species ROS generation 9. Overproduction of ROS results in cellular damage of lipids, membranes, and proteins 9.

Additionally, the oxidative state increases the risk of developing chronic diabetic complications following the DKA event 9.

Significant increase of IL-6, -1B and -8, and TNF-α and other cytokines reduce the response to insulin therapy. Insulin therapy and hydration are essential in normalizing these parameters 9.

In contrast to DKA, insulin production is not significantly reduced among HHS patients 4. This minimal insulin production is adequate to prevent lipolysis and ketogenesis 4 , 5.

HHS is characterized by severe elevations in serum glucose concentrations and hyperosmolality 4 , 5. This extreme elevation in serum hyperosmolality results in osmotic diuresis, a greater degree of dehydration, and more fluid loss than DKA 4 , 5.

This significant loss of intracellular fluids results in much higher blood glucose BG with HHS in comparison to DKA 4 , 5. Euglycemic DKA is another unique presentation of DKA and has been reported more often recently 6 , Euglycemic DKA has been linked with many factors, such as treatment of diabetes, carbohydrate restriction, high alcohol intake, and inhibition of gluconeogenesis 6 , It also can be induced due to certain medications, most commonly seen with sodium-glucose cotransporter 2 SGLT-2 inhibitors and insulin 6 , DKA develops more rapidly in comparison to HHS.

In some cases, it only takes a few hours from the precipitating factor for DKA to develop Both metabolic disorders present with classical hyperglycemia symptoms: polyuria, polydipsia, weakness, and mental status changes 6 , Additionally, patients with HHS and DKA often present with signs of dehydration, such as dry mucous membranes, poor skin turgor, tachycardia, hypotension, and increased capillary refill with severe dehydration 8 , If DKA worsens and is left without treatment, it can eventually lead to unconsciousness 6.

The initial laboratory assessment of patients with suspected DKA or HHS should include BG, blood urea nitrogen, serum creatinine, serum ketones, electrolytes, anion gap, osmolality, urine ketones, and arterial blood gases 6 , 8.

Other reasons for high anion gap metabolic acidosis, such as ethyl glycol toxicity, isoniazid overdose, lactic acidosis, methanol toxicity, propylene glycol ingestion, salicylates toxicity, and uremia, must be ruled out Diagnostic criteria for DKA and HHS are listed in Table 1 6.

Patients with a higher level of osmolarity and pH present with worse dehydration and mental status 4. DKA resolution is achieved following the correction of dehydration, hyperglycemia, and electrolyte imbalances 2 , 6 , 8.

In addition to the previously mentioned criteria, normal osmolality is required for HHS resolution 6 , 8. Figure 1 displays a suggested management pathway of DKA and HHS based on the American Diabetes Association ADA guidelines and Joint British Diabetes Societies for Inpatient Care JBDS-IP revised guidelines 1 , Figure 1 Pathway displays the management of diabetic ketoacidosis DKA and hyperglycemic hyperosmolar state HHS.

Fluid therapy is a cornerstone for the management of DKA and HHS. Aggressive repletion with isotonic saline expands the extracellular volume and stabilizes cardiovascular functions The initial fluid management general practice and protocols are based on the ADA guidelines statement for the management of hyperglycemic crises in adult patients with diabetes 1.

It recommends initiating 0. Half normal saline 0. During fluid replacement, it is expected that hyperglycemia will be corrected faster than ketoacidosis and DKA resolution 1. Appropriate assessment of serum osmolality, urine output, and cardiac function should be performed to guide the aggressive fluid administration and avoid iatrogenic overload 1.

However, optimal initial fluid therapy for managing DKA or HHS was not evident by clinical trials to evaluate the efficacy and safety outcomes of using normal saline or other crystalloid 1. It is known that using 0. Some practitioners may use balanced fluids as an alternative to overcome this side effect, as its different composition could physiologically lead to a faster resolution of acidosis Common types of crystalloid IV fluids and their composition are listed in Table 2 Small trials evaluated the effect of balanced fluids and 0.

They found that balanced crystalloids significantly resulted with a shorter median time for DKA resolution than saline At the same time, it significantly led to a shorter median time for insulin discontinuation than saline 9. They found no significant difference in DKA resolution at 48 hours, ICU, and hospital length of stay.

However, PL group had significantly reached more DKA resolution at 24 hours in comparison to 0. In conclusion, designing an appropriate fluid repletion therapy for DKA and HHS management will need careful planning and monitoring for choosing the appropriate fluid type, volume, and rate for the patient.

Insulin is considered to be one of the three fundamental elements of DKA and HHS management 2 , 6 , It reduces hepatic glucose synthesis, enhances peripheral glucose utilization, and inhibits lipolysis, ketogenesis, and glucagon secretion, lowering plasma glucose levels and decreasing ketone bodies production 6 , Insulin should be given immediately after the initial fluid resuscitation 2 , 6 , The aim of using insulin in DKA and HHS is to close the anion gap generated by the production of ketone bodies rather than aiming for euglycemia 6 , Intravenous administration of insulin regular mixed in NaCl 0.

Insulin can also be used as frequent subcutaneous or intramuscular injections for the treatment of DKA in mild-moderate DKA patients 6 , However, a continuous intravenous insulin regimen is preferred over subcutaneous insulin for DKA management overall due to its short half-life, fast onset, and easy titration 6 , The use of basal insulin analogs in conjunction with regular insulin infusions may speed up the resolution of DKA and minimize rebound hyperglycemia events, resulting in less ICU length of stay and less healthcare cost 6 , Insulin is currently recommended as a continuous infusion at 0.

Insulin loading dose has been linked to increasing the risk of cerebral edema and worsening shock Thus, insulin loading dose should be avoided at the beginning of therapy However, an insulin loading dose of 0. Multiple factors must be considered when titrating intravenous insulin continuous infusion 2.

The rate of blood glucose reduction, insulin sensitivity, prandial coverage, and NPO status should all be taken into consideration 2. A rapid reduction in BG might be harmful and linked to cerebral edema 2.

Moreover, the insulin infusion rate can be increased based on BG around major meals time and can be continued at a higher rate for hours following any major meal 2. Lastly, it is necessary to monitor BG among NPO patients closely. Randomized clinical trials compared the two strategies and found no difference 27 , Intravenous LD insulin administration has been associated with an increased risk of cerebral edema 27 , An acceptable alternative for patients with mild to moderate DKA could be a bolus of 0.

Patients with end-stage renal disease ESRD and acute kidney injury AKI are considered a high-risk category that necessitates extra care 32 , To avoid rapid increases in osmolality and hypoglycemia in these patients; it is recommended that insulin infusions begin at 0.

Subcutaneous insulin should overlap with intravenous insulin for at least minutes before its discontinuation to ensure the optimal transition of care 6 , A transition to subcutaneous long-acting insulin in addition to ultra-short acting insulin such as glargine and glulisine after resolution of DKA may result in reduced hypoglycemic events compared to other basal bolus regimens such as NPH insulin and insulin regular 24 , For newly diagnosed insulin-dependent diabetes patients, subcutaneous insulin may be started at a dose of 0.

The transition process in patients who were previously using insulin or antidiabetic agents before to DKA admission is still unclear 24 , In ICU settings, clinicians tend to hold all oral antidiabetic agents and rely on insulin regimens for in-patient management given the shorter half-life of insulin and its predictability 24 , This could potentially be an area for further investigation on the transition process and its implication on patient outcomes 24 , Insulin sequestering to plastic IV tubing has been described, resulting in insulin wasting and dose inaccuracy 34 , Flushing the IV tube with a priming fluid of 20 mL is adequate to minimize the insulin losses to IV tube 34 , Patients with hyperglycemic crisiss are at a higher risk of developing hypokalemia due to multifactorial process 1 , Insulin therapy, correction of acidosis, and hydration all together lead to the development of hypokalemia 1 , Additionally, volume depletion seen with hyperglycemic crisis leads to secondary hyperaldosteronism, which exacerbates hypokalemia by enhancing urinary potassium excretion 1 , Serum potassium level should be obtained immediately upon presentation and prior to initiating insulin therapy 1 , Potassium replacement is required regardless of the baseline serum potassium level due to hydration and insulin therapy, except among renal failure patients 1 , It is suggested to administer 20 —30 mEq potassium in each liter of intravenous fluid to keep a serum potassium concentration within the normal range 1 , In addition to possible hypokalemia, patients with the hyperglycemic crisis could present with hypophosphatemia 1 , Osmotic diuresis during hyperglycemic crisis increases the urinary phosphate excretion, and insulin therapy enhances intracellular phosphate shift 1 , Phosphate replacement is not a fundamental part of hyperglycemic crisis management, given the lack of evidence of clinical benefit 1 , 29 , A special consideration with phosphate administration is the secondary hypocalcemia 1 , 29 , Acidemia associated with DKA results from the overproduction of ketoacids, generated from the haptic metabolism of free fatty acids.

This hepatic metabolism occurs as a result of insulin resistance and an increase in the counterregulatory hormones contributing to the pathophysiology of DKA 37 , Tissue acidosis could lead to impaired myocardial contractility, systemic vasodilatation, inhibition of glucose utilization by insulin, and lowering the levels of 2,3-diphosphoglycerate 2,3-DPG in erythrocytes 37 — Sodium bicarbonate decreases the hemoglobin-oxygen affinity leading to tissue hypoxia; moreover, it is associated with hypernatremia, hypocalcemia, hypokalemia, hypercapnia, prolonged QTc interval, intracellular acidosis, and metabolic alkalosis 39 , The use of adjuvant sodium bicarbonate in the setting of DKA consistently shows a lack of clinical benefit and should be prescribed on a case-by-case basis.

Although this recommendation was not supported by solid evidence; many clinicians adopt the practice to avoid the unwanted side effect of severe metabolic acidosis. Sodium bicarbonate moves potassium intracellularly, however, clinical benefit is uncertain, and the use is controversial 41 , Prompt therapy for patients with hyperglycemic crisis is essential in reducing morbidity and mortality 6 , If not treated or treated ineffectively, the prognosis can include serious complications such as seizures, organ failures, coma, and death 6 , When treatment is delayed, the overall mortality rate of HHS is higher than that of DKA, especially in older patients.

This difference in prognoses was comparable when patients were matched for age Telemedicine options available. Learn more about our COVID response. Se habla Español. The Link Between High Blood Glucose and Foot Ulcers.

Diabetic Foot and Wound Center Blog The Link Between High Blood Glucose and Foot Ulcers. You Might Also Enjoy But did you know that it can also help improve your peripheral neuropathy symptoms? Continue reading to find out what exercise can do for you and how you can exercise safely.

Ingrown nails 一 which form when the side of your nail grows into the skin around your nail 一 often lead to tenderness and swelling. For diabetics, though, ingrown nails can be more problematic. Even the smallest foot sore can spell trouble if you have diabetes, but proper wound care can help you avoid complications.

It is the result of a combination of motor, autonomic, and sensory neuropathies in which there is muscle and joint laxity that lead to changes in the arches of the foot.

Further, the autonomic denervation leads to bone demineralization via the impairment of vascular smooth muscle, which leads to an increase in blood flow to the bone with a consequential osteolysis.

An illustration of some commonly described abnormalities is shown in Figure 1. In examining for vascular abnormalities of the foot, the dorsalis pedis and posterior tibial pulses should be palpated and characterized as present or absent.

If vascular disease is a concern, measuring the ankle brachial index ABI can be used in the outpatient setting for determining the extent of vascular disease and need for referral to a vascular specialist.

The ABI is obtained by measuring the systolic blood pressures in the ankles dorsalis pedis and posterior tibial arteries and arms brachial artery using a handheld Doppler and then calculating a ratio. Ratios below 0. However, in patients with calcified, poorly compressible vessels or aortoiliac stenosis, the results of the ABI can be complicated.

The loss of pressure sensation in the foot has been identified as a significant predictive factor for the likelihood of ulceration. A screening tool in the examination of the diabetic foot is the gauge monofilament.

The monofilament is tested on various sites along the plantar aspect of the toes, the ball of the foot, and between the great and second toe.

The test is considered reflective of an ulcer risk if the patient is unable to sense the monofilament when it is pressed against the foot with enough pressure to bend it.

The results of the foot evaluation should aid in developing an appropriate management plan. These classification systems are based on a variety of physical findings.

One of the most popular systems of classification is the Wagner Ulcer Classification System, which is based on wound depth and the extent of tissue necrosis Table 1. The University of Texas system is another classification system that addresses ulcer depth and includes the presence of infection and ischemia Table 2.

The management of diabetic foot ulcers includes several facets of care. Offloading and debridement are considered vital to the healing process for diabetic foot wounds. There are multiple methods of pressure relief, including total contact casting, half shoes, removable cast walkers, wheelchairs, and crutches.

There are advantages and disadvantages to each modality, and factors such as overall wound condition, required frequency for assessment, presence of infection, and the likelihood for patient compliance should be considered in determining which modality would be most beneficial to the patient.

The open diabetic foot ulcer may require debridement if necrotic or unhealthy tissue is present. The debridement of the wound will include the removal of surrounding callus and will aid in decreasing pressure points at callused sites on the foot.

Additionally, the removal of unhealthy tissue can aid in removing colonizing bacteria in the wound. It will also facilitate the collection of appropriate specimens for culture and permit examination for the involvement of deep tissues in the ulceration.

The selection of wound dressings is also an important component of diabetic wound care management. There are a number of available dressing types to consider in the course of wound care.

Although there is a dearth of published trials to support the use of one type of dressing compared to another, 26 the characteristics of specific dressing types can prove beneficial depending on the characteristics of the individual wound. Saline-soaked gauze dressings, for example, are inexpensive, well tolerated, and contribute to an atraumatic, moist wound environment.

Foam and alginate dressings are highly absorbent and can aid in decreasing the risk for maceration in wounds with heavy exudates. A complete discussion of the various classes of wound dressings is beyond the scope of this review; however, an ideal dressing should contribute to a moist wound environment, absorb excessive exudates, and not increase the risk for infections.

If infection is suspected in the wound, the selection of appropriate treatments should be based on the results of a wound culture. Tissue curettage from the base of the ulcer after debridement will reveal more accurate results than a superficial wound swab.

Gram-positive cocci are typically the most common pathogens isolated. However, chronic or previously treated wounds often show polymicrobial growth, including gram-negative rods or anaerobes. Pseudomonas, for example, is often cultured from wounds that have been soaked or treated with wet dressings.

Anaerobic bacteria are often cultured from ulcers with ischemic necrosis or deep tissue involvement. Antibiotic-resistant organisms such as methicillin-resistant staphylococcus aureus are frequently found in patients previously treated with antibiotic therapy or patients with a recent history of hospitalization or residence in a long-term care facility.

The selection of appropriate antimicrobial therapy, including the agent, route of administration, and need for inpatient or outpatient treatment will be determined in part by the severity of the infection. Clinical signs of purulent drainage, inflammatory signs of increased warmth, erythema, pain and induration, or systemic signs such as fever or leukocytosis should be considered.

Patients with systemic signs of severe infection should be admitted for supportive care and intravenous antibiotic therapy; additionally, a surgical evaluation is warranted to evaluate for a deep occult infection.

In the absence of serious signs, patients can be treated with outpatient therapy and frequent follow-up. Information about specific agents that have shown clinical effectiveness and suggested treatment schemes based on infection severity has been published elsewhere.

The possibility of underlying osteomyelitis should be considered with the presence of exposed bone or bone that can be palpated with a blunt probe.

If osteomyelitis is diagnosed, the patient may undergo surgical excision of the affected bone or an extensive course of antibiotic therapy.

Consideration is also given to the presence of underlying ischemia because an adequate arterial blood supply is necessary to facilitate wound healing and to resolve underlying infections. Patients with evidence of decreased distal blood flow or ulceration that does not progress toward healing with appropriate therapy should be referred to a vascular specialist.

Upon determination of the patient's anatomy and a vascular route amenable to restoration, the patient may undergo arterial revascularization. Surgical bypass is a common method of treatment for ischemic limbs, and favorable long-term results have been reported.

A number of adjunctive wound care treatments are under investigation and in practice for treating diabetic foot ulcers. The use of human skin equivalents has been shown to promote wound healing in diabetic ulcers via the action of cytokines and dermal matrix components that stimulate tissue growth and wound closure.

Two of the more popular adjunctive therapies in use are hyperbaric oxygen therapy HBOT and the use of granulocyte colony stimulating factors G-CSF. HBOT is the delivery of oxygen to patients at higher than normal atmospheric pressures.

This results in an increase in the concentration of oxygen in the blood and an increase in the diffusion capacity to the tissues. The partial pressure of oxygen in the tissues is increased, which stimulates neovascularization and fibroblast replication and increases phagocytosis and leukocyte-mediated killing of bacterial pathogens in the wound.

Presently, there are conflicting data regarding the efficacy of this therapy. Although small randomized studies have demonstrated an improvement in the rate of wound healing and a decrease in the number of amputations, 37 , 38 other studies contest these data.

The quality of the studies to date has been poor, and their findings have not been confirmed in a large, blinded, and adequately powered randomized trial. Diabetic wounds that meet the appropriate criteria are classified as Wagner Grade 3 wounds that have failed to resolve after a day course of standard treatment.

The use of G-CSF is another new adjunctive therapy under investigation. G-CSF has been found to enhance the activity of neutrophils in diabetic patients. A meta-analysis of these studies 41 revealed that, although the use of G-CSF did not significantly accelerate the resolution of infection in diabetic wounds, there was a decreased likelihood of amputation and the need for other surgical therapies in treated wounds.

Early detection of potential risk factors for ulceration can decrease the frequency of wound development. It is recommended that all patients with diabetes undergo foot examinations at least annually to determine predisposing conditions to ulceration.

A risk classification scheme has been created in the report of the task force of the Foot Care Interest Group of the ADA 13 that is reportedly designed to make basic recommendations regarding the need for specialist referral and the frequency of follow-up by primary providers and specialists Table 3.

Patients in the lowest risk category are recommended to receive education on general foot care and annual follow-up.

To request an appointment, Hyperglycemic crisis and diabetic foot ulcers For referrals, foto To request crisls records, fax COVID Update: click here to learn more. Diabetes is major health issue in the United States, and in the southeast, approximately 15 percent of the population is diabetic. With all Fish Species Conservation Programs, your feet might be Performance recovery last thing on your mind. But Hyperglycemic crisis and diabetic foot ulcers care crjsis one of the Hyperglycemicc ways to prevent foot djabetic. About half of all people with diabetes have some kind of nerve damage. You can have nerve damage in any part of your body, but nerves in your feet and legs are most often affected. Nerve damage can cause you to lose feeling in your feet. Some people with nerve damage have numbness, tingling, or pain, but others have no symptoms. Hyperglycemic crisis and diabetic foot ulcers

Author: Tar

2 thoughts on “Hyperglycemic crisis and diabetic foot ulcers

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com